Bank Of New York Mellon Corp Eton Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.89 - $4.1 $229,471 - $325,548	79,402 New	79,402 $306 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $159,321 - $256,334	78,872 New	78,872 $222,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.38 $1,486 - $2,553	-583 Reduced 0.73%	78,872 $207,000
Q4 2021 Feb 11, 2022	SELL	$3.66 - $6.59 $988 - $1,779	-270 Reduced 0.34%	79,455 $341,000
Q3 2021 Nov 12, 2021	BUY	$4.2 - $6.26 $279,090 - $415,977	66,450 Added 500.56%	79,725 $401,000
Q2 2021 Aug 11, 2021	SELL	$5.71 - $8.85 $183,359 - $284,191	-32,112 Reduced 70.75%	13,275 $81,000
Q1 2021 May 13, 2021	SELL	$6.93 - $10.07 $1,801 - $2,618	-260 Reduced 0.57%	45,387 $332,000
Q4 2020 Feb 09, 2021	BUY	$6.65 - $8.83 $78,323 - $103,999	11,778 Added 34.78%	45,647 $371,000
Q3 2020 Nov 12, 2020	BUY	$4.96 - $9.06 $1,562 - $2,853	315 Added 0.94%	33,869 $267,000
Q2 2020 Aug 12, 2020	BUY	$3.5 - $6.09 $117,439 - $204,343	33,554 New	33,554 $182,000

9.43M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $422M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.